Inactive Instrument

Norda ASA Stock Oslo Bors

Equities

NORD

NO0010285190

Biotechnology & Medical Research

Sales 2021 139M 12.65M Sales 2022 128M 11.62M Capitalization 204M 18.51M
Net income 2021 82M 7.45M Net income 2022 100M 9.08M EV / Sales 2021 0.22 x
Net cash position 2021 159M 14.42M Net cash position 2022 257M 23.32M EV / Sales 2022 -0.41 x
P/E ratio 2021 *
-
P/E ratio 2022
-
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 6.26%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 13-04-07
Members of the board TitleAgeSince
Director/Board Member 66 13-06-19
Chairman 52 12-06-20
Director/Board Member - -
More insiders
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
More about the company